SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Giannakoulas, G.
Right arrow Articles by Louridas, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannakoulas, G.
Right arrow Articles by Louridas, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stroke
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

N-Terminal Pro-Brain Natriuretic Peptide Levels Are Elevated in Patients with Acute Ischemic Stroke

George Giannakoulas, MD

First Department of Cardiology, AHEPA General Hospital, Aristotle University of Thessaloniki, giannak{at}med.auth.gr

Apostolos Hatzitolios, MD, PhD

First Propedeutic Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki

Haralambos Karvounis, MD, PhD

First Department of Cardiology, AHEPA General Hospital, Aristotle University of Thessaloniki

George Koliakos, MD, PhD

Department of Biochemistry, Aristotle University of Thessaloniki, Greece

Aphrodite Charitandi, MD, PhD

Radiology Department, AHEPA General Hospital, Aristotle University of Thessaloniki

Theodoros Dimitroulas, MD

First Propedeutic Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki

Christos Savopoulos, MD, PhD

First Propedeutic Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki

Efrosini Tsirogianni, MD

First Propedeutic Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki

George Louridas, MD, PhD

First Department of Cardiology, AHEPA General Hospital, Aristotle University of Thessaloniki

Brain natriuretic peptide (BNP) is a counterregulatory hormone released by the ventricles of the heart. Its main actions are natriuresis and vasodilation. The authors studied N-terminal pro-brain natriuretic peptide (NT-proBNP) levels soon after an acute ischemic stroke. They compared plasma NT-proBNP concentrations in 30 patients with an acute ischemic stroke with those of 30 controls. The 2 groups were adjusted for age and gender, and there were no significant differences in vascular risk factors and left ventricular systolic and diastolic function. Venous samples were collected within the first 11.8 ±1.2 hours after the onset of symptoms and again on day 6. Brain computed tomography/magnetic resonance imaging (CT/MRI) was performed on the same days (day 0 and day 6) in order to assess the site (carotid or vertebrobasilar), cause (atherothrombotic, cardioembolic, or lacunar), and size (large, medium, or small) of the brain infarct. NT-proBNP levels were elevated in patients with acute stroke (129.9 ±9.9 fmol/mL) compared with the controls (90.8 ±6.3 fmol/mL, p<0.05). These levels remained elevated at day 6 (113.5 ±13.0 fmol/mL). NT-proBNP at admission was significantly higher in cardioembolic compared with atherothrombotic infarctions. There was no correlation between circulating NT-proBNP and stroke topography, infarct size, or severity as assessed by the National Institutes of Health Stroke Scale (NIHSS) at any of the 2 time points (admission and day 6). NT-proBNP levels were raised in patients with acute ischemic stroke; this effect persisted until day 6. The authors suggest that neurohumoral activation occurs in patients with acute ischemic stroke, either reflecting a counterbalancing vasodilating response to the cerebral ischemia or direct myocardial dysfunction.

Angiology, Vol. 56, No. 6, 723-730 (2005)
DOI: 10.1177/000331970505600610


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Intensive Care MedHome page
M. Y. Rady
B-Type Natriuretic Peptide and Sepsis: It Is Not Just the Heart
J Intensive Care Med, November 1, 2007; 22(6): 386 - 388.
[PDF]



Advertisement